Unlike SAAs, NSAAs have little or no capacity to activate the AR, show no off-target hormonal activity such as progestogenic, glucocorticoid, or antimineralocorticoid activity, and lack antigonadotropic effects. For these reasons, they have improved efficacy and selectivity as<unk> s and do not lower androgen levels, instead acting solely by directly blocking the actions of androgens at the level of their biological target, the AR.
Nonsteroidal antiandrogen
Antiandrogen
Steroidal antiandrogen
Nonsteroidal estrogen
Antiprogestogen
Antiestrogen
N-Terminal domain antiandrogen
Thyroid blocker